- Home
- FDUS vs NMRA Comparison
FDUS vs NMRA Comparison
Compare FDUS & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | FDUS | NMRA |
|---|---|---|
| Founded | 2011 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 642.2M | 554.0M |
| IPO Year | 2011 | 2023 |
Fundamental Metrics
Financial Performance| Metric | FDUS | NMRA |
|---|---|---|
| Price | $17.87 | $2.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $21.17 | $6.57 |
| AVG Volume (30 Days) | 312.2K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 11.89% | N/A |
| EPS Growth | N/A | ★ 5.23 |
| EPS | ★ 2.08 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.39 | N/A |
| Revenue Next Year | $8.79 | N/A |
| P/E Ratio | $8.61 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.87 | $0.63 |
| 52 Week High | $22.09 | $3.65 |
Technical Indicators
Market Signals| Indicator | FDUS | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 50.88 | 35.52 |
| Support Level | $17.41 | $2.10 |
| Resistance Level | $18.66 | $2.20 |
| Average True Range (ATR) | 0.47 | 0.17 |
| MACD | 0.06 | -0.07 |
| Stochastic Oscillator | 60.90 | 27.78 |
Price Performance
Historical ComparisonAbout FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investment is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.